EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Transcriptional phenotype of the anti-parasitic benzodiazepine meclonazepam on the blood fluke Schistosoma mansoni

Clair R Henthorn, Paul McCusker, Winka Le Clec'h, Frédéric D Chevalier iD, Timothy J C Anderson iD, Mostafa Zamanian iD, John D Chan iD

PLOS Neglected Tropical Diseases · 08.04.2025 · 19 (4) · e0012969

DOI: 10.1371/journal.pntd.0012969 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS Neglected Tropical Diseases, online erschienen am 08.04.2025. Verfasst von Clair R Henthorn und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathobiological Sciences, University of Wisconsin-Madison, Madison, Wisconsin, United States of America. Hauptthemen laut MEDLINE: Schistosoma mansoni, Anthelmintics, Benzodiazepines. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 83 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, NCRR NIH HHS, NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

There are limited control measures for the disease schistosomiasis, despite the fact that infection with parasitic blood flukes affects hundreds of millions of people worldwide. The current treatment, praziquantel, has been in use since the 1980’s and there is a concern that drug resistance may emerge with continued monotherapy. Given the need for additional antischistosomal drugs, we have re-visited an old lead, meclonazepam. In comparison to praziquantel, there has been relatively little work on its antiparasitic mechanism. Recent findings indicate that praziquantel and meclonazepam act through distinct receptors, making benzodiazepines a promising chemical series for further exploration. Previous work has profiled the transcriptional changes evoked by praziquantel treatment. Here, we examine in detail schistosome phenotypes evoked by in vitro and in vivo meclonazepam treatment. These data confirm that meclonazepam causes extensive tegument damage and directly kills parasites, as measured by pro-apoptotic caspase activation. In vivo meclonazepam exposure results in differential expression of many genes that are divergent in parasitic flatworms, as well as several gene products implicated in blood feeding and regulation of hemostasis in other parasites. Many of these transcripts are also differentially expressed with praziquantel exposure, which may reflect a common schistosome response to the two drugs. However, despite these similarities in drug response, praziquantel-resistant parasites retain susceptibility to meclonazepam’s schistocidal effects. These data provide new insight into the mechanism of antischistosomal benzodiazepines, resolving similarities and differences with the current frontline therapy, praziquantel.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Schistosoma mansoniAnthelminticsBenzodiazepinesAnimalsSchistosomiasis mansoniMicePraziquantelFemalePhenotypeGene Expression ProfilingMale

Substanzen

AnthelminticsPraziquantelBenzodiazepines

Autor:innen und Institutionen

  • Department of Pathobiological Sciences, University of Wisconsin-Madison, Madison, Wisconsin, United States of America.
  • Department of Cell Biology, Neurobiology & Anatomy, Medical College of Wisconsin, Milwaukee, Wisconsin, United States of America.
  • Institute for Global Food Security, School of Biological Sciences, Queen's University Belfast, Belfast, United Kingdom.
  • Disease Intervention & Prevention Program, Texas Biomedical Research Institute, San Antonio, Texas, United States of America.
  • Disease Intervention and Prevention program, Texas Biomedical Research Institute, San Antonio, Texas, United States of America.
  • Global Health Institute, University of Wisconsin-Madison, Madison, Wisconsin, United States of America.

ORCID-Profile: Frédéric D Chevalier, Timothy J C Anderson, Mostafa Zamanian, John D Chan

Förderung

  • NIAID NIH HHS
  • NCRR NIH HHS
  • NIH HHS
  • NIH-NIAID
  • University of Wisconsin System

Zitieren

APA

Henthorn, C. R., McCusker, P., Le Clec'h, W., Chevalier, F. D., Anderson, T. J. C., Zamanian, M., & Chan, J. D. (2025). Transcriptional phenotype of the anti-parasitic benzodiazepine meclonazepam on the blood fluke Schistosoma mansoni. PLOS Neglected Tropical Diseases, 19(4), e0012969. https://doi.org/10.1371/journal.pntd.0012969

Vancouver

Henthorn CR, McCusker P, Le Clec'h W, Chevalier FD, Anderson TJC, Zamanian M, et al. Transcriptional phenotype of the anti-parasitic benzodiazepine meclonazepam on the blood fluke Schistosoma mansoni. PLOS Neglected Tropical Diseases. 2025;19(4):e0012969. doi:10.1371/journal.pntd.0012969

BibTeX
@article{Henthorn2025,
  author = {Henthorn, Clair R and McCusker, Paul and Le Clec'h, Winka and Chevalier, Frédéric D and Anderson, Timothy J C and Zamanian, Mostafa and Chan, John D},
  title = {Transcriptional phenotype of the anti-parasitic benzodiazepine meclonazepam on the blood fluke Schistosoma mansoni},
  journal = {PLOS Neglected Tropical Diseases},
  year = {2025},
  volume = {19},
  number = {4},
  pages = {e0012969},
  doi = {10.1371/journal.pntd.0012969}
}
Kostenlos starten →